A patient with vCJD who showed “remarkable” improvement after a controversial
drug treatment has died after reportedly suffering liver damage. Rachel Forber
was diagnosed with the human form of mad cow disease in June. Two months later
she began a course of chlorpromazine, an antipsychotic, and quinacrine, which is
normally used against malaria. Laboratory tests suggested that both drugs can
block the formation of prions, which cause vCJD. “It’s terrible for hope to be
given and then snatched away like that. We’re right back where we started with
no cure,” says Francis Hall of Britain’s Human BSE Foundation. But authorities…
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
We've found a mysterious substance on Titan and Pluto
2
A quantum state that lasts forever may finally be within our grasp
3
Has the answer to life's origins been hiding in our cells all along?
4
Fully autonomous drones have killed human soldiers for the first time
5
Carl Sagan's The Demon-Haunted World is still supremely relevant today
6
Can prebiotics, probiotics or postbiotics help your ageing microbiome?
7
Faecal transplant makes the brains of old mice act young again
8
The secrets to keeping your brain sharp in old age
9
The last-ditch plan to save coral reefs from utter destruction
10
Remarkable fossils rewrite the story of how animals conquered the land



